![](/images/Email.png)
TargetProstaglandin E2 receptor EP3 subtype(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 1.10nMAssay Description:Inhibition of EP3 receptorMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP3 subtype(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 1.30nMAssay Description:Binding affinity to EP3 receptorMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP3 subtype(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 263nMAssay Description:Inhibition of EP3 receptor in presence of 0.005 % HASMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP3 subtype(Homo sapiens (Human))
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Bristol-Myers Squibb Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataKi: 280nMAssay Description:Binding affinity to EP3 receptor in presence of HSAMore data for this Ligand-Target Pair
![](/img/powered_by_small.gif)